NASDAQ:ACOG Alpha Cognition (ACOG) Stock Price, News & Analysis $9.04 0.00 (0.00%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$9.00 -0.04 (-0.44%) As of 10/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Alpha Cognition Stock (NASDAQ:ACOG) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Alpha Cognition alerts:Sign Up Key Stats Today's Range$8.93▼$9.1850-Day Range$8.40▼$9.7552-Week Range$4.50▼$10.14Volume20,347 shsAverage Volume110,947 shsMarket Capitalization$196.89 millionP/E RatioN/ADividend YieldN/APrice Target$18.00Consensus RatingBuy Company Overview Alpha Cognition Inc. (NASDAQ: ACOG) is a biopharmaceutical company focused on developing and commercializing treatments for neurodegenerative disorders, including Alzheimer’s disease and related cognitive conditions. The company’s work is centered on addressing unmet needs in the diagnosis, management and treatment of diseases that affect memory and cognitive function. Its lead commercial product is ZUNOVO (memantine hydrochloride extended-release capsules), a prescription therapy approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer’s type. The company is also advancing additional drug candidates, including ALPHA-1062, an investigational formulation of galantamine intended for potential use in Alzheimer’s disease. Alpha Cognition is headquartered in Vancouver, British Columbia, and serves the U.S. pharmaceutical market through its development and commercialization activities. The company is led by Chief Executive Officer Michael McFadden.AI Generated. May Contain Errors. Read More Alpha Cognition Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks73rd Percentile Overall ScoreACOG MarketRank™: Alpha Cognition scored higher than 73% of companies evaluated by MarketBeat, and ranked 132nd out of 883 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingBuy Consensus RatingAlpha Cognition has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 5 buy ratings, no hold ratings, and no sell ratings.Upside PotentialAlpha Cognition has a consensus price target of $18.00, representing about 99.1% upside from its current price of $9.04.Amount of Analyst CoverageAlpha Cognition has only been the subject of 3 research reports in the past 90 days.Read more about Alpha Cognition's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Alpha Cognition are expected to grow in the coming year, from ($1.38) to ($0.61) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alpha Cognition is -8.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alpha Cognition is -8.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAlpha Cognition has a P/B Ratio of 3.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Alpha Cognition's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.62% of the float of Alpha Cognition has been sold short.Short Interest Ratio / Days to CoverAlpha Cognition has a short interest ratio ("days to cover") of 2.79, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Alpha Cognition has recently increased by 54.57%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAlpha Cognition does not currently pay a dividend.Dividend GrowthAlpha Cognition does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.43 News SentimentAlpha Cognition has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Alpha Cognition this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added Alpha Cognition to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Company Ownership3.2 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $96,200.00 in company stock, which represents 0.0489% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Alpha Cognition insiders have bought more of their company's stock than they have sold. Specifically, they have bought $96,200.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders8.60% of the stock of Alpha Cognition is held by insiders.Percentage Held by InstitutionsAlpha Cognition has minimal institutional ownership at this time.Read more about Alpha Cognition's insider trading history. Receive ACOG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alpha Cognition and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACOG Stock News HeadlinesAlpha Cognition Inc. (NASDAQ:ACOG) Stock Has Average Target Price of $18.00October 8 at 4:15 AM | americanbankingnews.comAnalysts Offer Insights on Healthcare Companies: Alpha Cognition Inc (ACOG) and Travere Therapeutics (TVTX)October 3, 2026 | theglobeandmail.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.October 10 at 1:00 AM | Stansberry Research (Ad)Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2026 | financialpost.comFAlpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2026 | businesswire.comOpaleye adds to Alpha Cognition stakeOctober 1, 2026 | americanbankingnews.comMajor Investor Quietly Ramps Up Stake in Alpha Cognition Inc.September 28, 2026 | tipranks.comAlpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 9, 2026 | financialpost.comFSee More Headlines ACOG Stock Analysis - Frequently Asked Questions How have ACOG shares performed this year? Alpha Cognition's stock was trading at $6.50 at the beginning of the year. Since then, ACOG shares have increased by 39.1% and is now trading at $9.04. How were Alpha Cognition's earnings last quarter? Alpha Cognition Inc. (NASDAQ:ACOG) issued its quarterly earnings results on Thursday, August, 13th. The company reported ($0.40) earnings per share for the quarter, missing analysts' consensus estimates of ($0.39) by $0.01. The company had revenue of $6 million for the quarter, compared to the consensus estimate of $4.38 million. Alpha Cognition had a negative net margin of 153.61% and a negative trailing twelve-month return on equity of 54.60%. Read the conference call transcript. When did Alpha Cognition IPO? Alpha Cognition (ACOG) raised $50 million in an IPO on Tuesday, November 12th 2024. The company issued 8,695,653 shares at $5.75 per share. How do I buy shares of Alpha Cognition? Shares of ACOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/13/2026Today10/10/2026Next Earnings (Estimated)11/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (11m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 ACOG's financial health is in the Yellow zone, according to TradeSmith. ACOG has been in this zone for over 11 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:ACOG CIK1655923 Webwww.alphacognition.com Phone(858) 344-4375FaxN/AEmployees71Year FoundedN/APrice Target and Rating Average Price Target for Alpha Cognition$18.00 High Price Target$21.00 Low Price Target$12.00 Potential Upside/Downside+99.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($1.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$20.67 million Net Margins-153.61% Pretax Margin-137.70% Return on Equity-54.60% Return on Assets-43.47% Debt Debt-to-Equity RatioN/A Current Ratio9.03 Quick Ratio8.04 Sales & Book Value Annual Sales$10.22 million Price / Sales19.27 Cash FlowN/A Price / Cash FlowN/A Book Value$2.88 per share Price / Book3.14Miscellaneous Outstanding Shares21,780,000Free Float19,905,000Market Cap$196.89 million OptionableN/A Beta2.32 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:ACOG) was last updated on 10/10/2026 by MarketBeat.com Staff. From Our PartnersThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredThis high yielding “gold annuity” is starting to move…Garrett Goggin, a 20+ year gold analyst, has called major moves before: Montage Gold up 2,567%, G2 Goldfields ...Golden Portfolio | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...TradeWins | SponsoredNew Chip takes minutes, not daysGeorge Gilder believes today's AI data centers could become tomorrow's typewriters - replaced by a single wafe...Eagle Publishing | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Cognition Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Cognition With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
